Skip to main content
. 2021 Apr 1;5(7):1853–1861. doi: 10.1182/bloodadvances.2020004018

Figure 2.

Figure 2.

MRD at EOI. Prevalence of MRD ≥0.01% at EOI in the IDEAL cohort as compared with historical controls and stratified by starting BMI. In the IDEAL trial, 24 of 38 (63%) evaluable for MRD at EOI were OW/OB as compared with 35 of 80 (44%) in the historical control.